Treats pain associated with true trigeminal neuralgia. ANDA 75948, held by Apotex. Carbamazepine.
As of Nov 16, 2026, ANDA 75948 (Carbamazepine), held by Apotex, was first approved by FDA on Feb 27, 2002, with 14 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Epilepsy Carbamazepine tablets are indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. Generalized tonic-clonic seizures (grand mal). Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine (see PRECAUTIONS, General ).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 27, 2002 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Carbamazepine200MG · tablet;oral | Carbamazepine | Rx |
| Oct 14, 2026 | Supplement 23Labeling · Standard review | Approved | None posted |
| Mar 6, 2026 | Supplement 22Labeling · Standard review | Approved | None posted |
| Jan 29, 2024 | Supplement 21Labeling · Standard review | Approved | None posted |
| Nov 8, 2022 | Supplement 19Labeling · Standard review | Approved | None posted |
| Apr 20, 2020 | Supplement 14Labeling · Standard review | Approved | None posted |
| Apr 20, 2020 | Supplement 12Labeling · Standard review | Approved | None posted |
| Feb 18, 2015 | Supplement 11Labeling · Standard review | Approved | None posted |
| Feb 18, 2015 | Supplement 10Labeling · Standard review | Approved | None posted |
| Feb 18, 2015 | Supplement 9Labeling · Standard review | Approved | None posted |
| Feb 18, 2015 | Supplement 8Labeling · Standard review | Approved | None posted |
| Nov 4, 2011 | Supplement 7REMS | Approved | None posted |
| Nov 25, 2009 | Supplement 6Labeling | Approved | None posted |
| Jul 28, 2008 | Supplement 3Labeling | Approved | None posted |
| Oct 15, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Feb 27, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters